From landmark publications (Nature Protocols, 2× Cell) to doubling our team and strengthening our platform, 2025 was a big year.
We wrapped it up with our inaugural R&D Day, bringing together our team and collaborators to share rapid progress across our small-molecule pipeline for age-related diseases and our platform at the intersection of biology, chemistry, and AI.
Heading into 2026 with momentum and ready to break new ground.